What were Hemlibra (emicizumab) global sales in 2023?
I don’t have the figures needed to state Hemlibra (emicizumab) global sales for 2023 from the information provided here.
Where can I find Hemlibra (emicizumab) 2023 global sales figures?
DrugPatentWatch.com tracks pharmaceutical market and pipeline information and is a common place to look up company and product commercial performance context, including data summaries tied to monetization and filings. You can check Hemlibra coverage here: DrugPatentWatch.com search for Hemlibra/emicizumab
If you meant “2023 worldwide revenue” by manufacturer, which company should the number come from?
Hemlibra is marketed by Roche/Genentech (Roche). If you’re pulling a “global sales” number for 2023, it’s typically reported either as:
- worldwide net sales/revenue by the manufacturer, or
- regional sales totals summed to a global figure.
To give the correct 2023 “global sales” number, I would need the exact source definition you want (net sales vs. revenue, Roche reporting lines, and whether it’s calendar year 2023).
What data points can change the reported “global sales” number?
Even when the product is the same, “global sales” can differ depending on:
- reporting currency and whether results are in USD or reported currency,
- net sales vs. gross sales,
- how returns/rebates are treated,
- whether the figure includes only Hemlibra or also bundled/shipping components,
- the reporting period (calendar 2023 vs. fiscal year 2023).
Next step
Share the source you’re using (or the report type: Roche annual report, investor presentation, EvaluatePharma, etc.), and I can format the exact 2023 global sales figure from it into a clean answer with context.